Elsevier

Annals of Oncology

Volume 9, Issue 12, December 1998, Pages 1269-1276
Annals of Oncology

Review
The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: Use, limitations and future of RNA-based methods

https://doi.org/10.1023/A:1008445604263Get rights and content
Under an Elsevier user license
open archive

Summary

Background

Many solid tumors commonly metastasize to the bone marrow and the presence of tumor cells in the bone marrow is associated with a poor prognosis. Detection of tumor cells in the bone marrow has been reported to be important to determine the prognosis of newly diagnosed patients and may be helpful in deciding whether or not systemic treatment is indicated.

Patients and methods

The majority of the studies focus on the detection of tumor cells in non-tumor tissue using immunocytochemistry and antibodies directed against epitopes of epithelial genes. Recently, the sensitive reverse-transcriptase polymerase chain reaction (RT–PCR) has been employed for the detection of tumor cells in bone marrow, using mRNA transcribed from epithelial genes as targets for RT–PCR.

Results

In some studies, encouraging results were reported when RT–PCR was used to detect expression of epithelial genes, but in many others frequent false-positive results were observed. These may result from the ‘illegitimate expression’ of epithelial genes in cells of non-epithelial tissues, such as bone marrow.

Conclusions

Micrometastases in bone marrow can be detected with some sensitivity by antibodies directed against epithelial genes. RNA based methods, using epithelial genes as target for amplification, are less reliable. To improve these methods, a systematic approach is required to identify genes which are highly expressed in solid tumors and completely silent in blood and bone marrow of healthy individuals. Novel techniques, e.g., ‘sequential analysis of gene expression’ (SAGE), are now available that allow such an endeavor.

Key words

epithelial tumor cells
immunocytochemistry
minimal disease
prognosis
RNA-based methods

Cited by (0)